| Primary |
| Chronic Obstructive Pulmonary Disease |
49.5% |
| Hypertension |
9.2% |
| Emphysema |
7.3% |
| Asthma |
6.7% |
| Blood Cholesterol Increased |
4.0% |
| Dyspnoea |
4.0% |
| Prophylaxis |
2.3% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Diabetes Mellitus |
1.9% |
| Cardiac Disorder |
1.8% |
| Bronchitis Chronic |
1.7% |
| Anxiety |
1.5% |
| Depression |
1.4% |
| Hypothyroidism |
1.4% |
| Supplementation Therapy |
1.2% |
| Atrial Fibrillation |
1.0% |
| Pain |
0.8% |
| Arthritis |
0.8% |
| Hypersensitivity |
0.7% |
| Bronchitis |
0.7% |
|
| Incorrect Route Of Drug Administration |
55.0% |
| Dyspnoea |
12.3% |
| Drug Ineffective |
9.6% |
| Product Quality Issue |
3.3% |
| Pneumonia |
2.4% |
| Vision Blurred |
2.3% |
| Death |
1.8% |
| Off Label Use |
1.7% |
| Dry Mouth |
1.6% |
| Urinary Retention |
1.5% |
| Wheezing |
1.5% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
| Cough |
0.9% |
| Dysphonia |
0.8% |
| Rash |
0.8% |
| Throat Irritation |
0.8% |
| Lung Neoplasm Malignant |
0.8% |
| Malaise |
0.7% |
| Urinary Tract Infection |
0.7% |
| Headache |
0.7% |
|
| Secondary |
| Chronic Obstructive Pulmonary Disease |
40.5% |
| Emphysema |
11.6% |
| Asthma |
9.7% |
| Dyspnoea |
7.9% |
| Hypertension |
6.3% |
| Bronchitis Chronic |
3.7% |
| Product Used For Unknown Indication |
3.0% |
| Blood Cholesterol Increased |
2.4% |
| Drug Use For Unknown Indication |
1.7% |
| Bronchitis |
1.6% |
| Prophylaxis |
1.6% |
| Depression |
1.3% |
| Cardiac Disorder |
1.3% |
| Diabetes Mellitus |
1.3% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Atrial Fibrillation |
1.1% |
| Anxiety |
1.1% |
| Hypothyroidism |
0.9% |
| Lung Disorder |
0.9% |
| Osteoporosis |
0.7% |
|
| Incorrect Route Of Drug Administration |
68.8% |
| Dyspnoea |
7.7% |
| Drug Ineffective |
6.7% |
| Pneumonia |
2.6% |
| Vision Blurred |
1.8% |
| Wheezing |
1.3% |
| Urinary Retention |
1.2% |
| Off Label Use |
1.1% |
| Dry Mouth |
1.1% |
| Product Quality Issue |
0.9% |
| Cough |
0.9% |
| Hypersensitivity |
0.7% |
| Weight Increased |
0.7% |
| Dysgeusia |
0.7% |
| Urticaria |
0.7% |
| Vomiting |
0.6% |
| Urinary Tract Infection |
0.6% |
| Chronic Obstructive Pulmonary Disease |
0.6% |
| Dysphonia |
0.6% |
| Visual Acuity Reduced |
0.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.0% |
| Drug Use For Unknown Indication |
15.4% |
| Chronic Obstructive Pulmonary Disease |
15.3% |
| Asthma |
8.6% |
| Hypertension |
5.7% |
| Pain |
3.3% |
| Osteoporosis |
2.7% |
| Non-small Cell Lung Cancer |
2.6% |
| Emphysema |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Depression |
2.2% |
| Smoking Cessation Therapy |
2.1% |
| Prophylaxis |
2.1% |
| Atrial Fibrillation |
1.9% |
| Diabetes Mellitus |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
| Anxiety |
1.3% |
| Hypersensitivity |
1.1% |
| Dyspnoea |
1.1% |
|
| Pneumonia |
11.8% |
| Dyspnoea |
9.0% |
| Vomiting |
9.0% |
| Weight Decreased |
8.2% |
| Death |
6.9% |
| Weight Increased |
6.6% |
| Chronic Obstructive Pulmonary Disease |
5.0% |
| Nausea |
4.6% |
| Wheezing |
4.5% |
| Respiratory Failure |
4.0% |
| Product Quality Issue |
3.8% |
| Drug Ineffective |
3.7% |
| Pyrexia |
3.3% |
| Tremor |
3.2% |
| Renal Failure Acute |
2.9% |
| Urinary Tract Infection |
2.9% |
| Rash |
2.9% |
| Oedema Peripheral |
2.7% |
| Pain In Extremity |
2.4% |
| Somnolence |
2.4% |
|
| Interacting |
| Chronic Obstructive Pulmonary Disease |
28.8% |
| Emphysema |
21.2% |
| Asthma |
18.5% |
| Smoking Cessation Therapy |
11.6% |
| Hypertension |
2.7% |
| Constipation |
2.1% |
| Drug Use For Unknown Indication |
2.1% |
| Depression |
1.4% |
| Ex-smoker |
1.4% |
| Ex-tobacco User |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Respiratory Tract Infection |
1.4% |
| Venous Stasis |
1.4% |
| Anxiety |
0.7% |
| Arthritis |
0.7% |
| Back Pain |
0.7% |
| Blood Pressure Diastolic Abnormal |
0.7% |
| Bronchitis Chronic |
0.7% |
| Cardiac Disorder |
0.7% |
| Cystitis |
0.7% |
|
| Weight Increased |
15.0% |
| Vomiting |
12.5% |
| Drug Interaction |
10.0% |
| Dyspnoea |
10.0% |
| Tachycardia |
7.5% |
| Pneumonia |
5.0% |
| Respiratory Tract Infection |
5.0% |
| Tongue Disorder |
5.0% |
| Tremor |
5.0% |
| Drug Ineffective |
2.5% |
| Dysphonia |
2.5% |
| Headache |
2.5% |
| Hypogammaglobulinaemia |
2.5% |
| Lung Disorder |
2.5% |
| Muscular Weakness |
2.5% |
| Purpura |
2.5% |
| Respiratory Distress |
2.5% |
| Shoulder Operation |
2.5% |
| Wheezing |
2.5% |
|